Alpha-lipoic acid (ALA) is a powerful antioxidant that can help reduce the harmful effects of
free radicals in the body. When the body is fighting sepsis, the immune response generates a
lot of free radicals that can damage cells and tissues. ALA can neutralize these free
radicals, reducing oxidative stress and preventing damage to cells and tissues.
ALA also has anti-inflammatory properties, meaning it can reduce inflammation in the body.
Inflammation is a key feature of sepsis, and it can cause damage to organs and tissues. By
reducing inflammation, ALA can help prevent damage to organs and tissues, reducing the risk
of sepsis complications such as organ failure.
The objective of this research is to investigate the impact of ALA on individuals who have
sepsis. The study will involve dividing the participants into two groups: a control group and
an ALA group. The control group will receive the standard supportive care for sepsis
management. Meanwhile, the ALA group will receive 1200 mg of ALA daily in addition to the
standard care.